WallStSmart
GRDN

Guardian Pharmacy Services, Inc.

NYSE: GRDN · HEALTHCARE · MEDICAL CARE FACILITIES

$35.65
-0.78% today

Updated 2026-06-05

Market cap
$2.73B
P/E ratio
51.30
P/S ratio
1.87x
EPS (TTM)
$0.84
Dividend yield
52W range
$19 – $44
Volume
0.4M

Guardian Pharmacy Services, Inc. (GRDN) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20182019202020212022202320242025
Operating cash flow$43.67M$56.16M$52.61M$58.50M$48.52M$70.82M$57.96M$100.29M
Capital expenditures$10.01M$14.54M$8.34M$9.28M$16.77M$14.56M$16.37M$19.58M
Depreciation
Stock-based comp$5.98M$1.93M$3.21M$13.03M$-3.38M$-6.09M$131.49M$13.85M
Free cash flow$33.67M$41.62M$44.27M$49.22M$31.75M$56.26M$41.59M$80.71M
Investing cash flow
Financing cash flow
Dividends paid$27.99M$34.32M$10.82M$17.36M$30.80M$38.42M$35.75M$0.00
Share repurchases
Debt repayment
Net change in cash

Frequently asked questions

What is Guardian Pharmacy Services, Inc.'s revenue?

Guardian Pharmacy Services, Inc.'s trailing twelve-month revenue is $1.46B. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is GRDN?

In its most recent fiscal year, GRDN ran a gross margin of 19.47%, an operating margin of 6.14%, and a net margin of 3.40%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does GRDN generate?

GRDN produced $80.71M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is GRDN's balance sheet healthy?

GRDN holds $65.62M in cash and equivalents against — in long-term debt, on $205.76M of shareholder equity. That debt is best read against the cash flow the business throws off each year.